(Q35249946)

7 August 2017

1 reference

title

Adrenergic beta-blocking agents (English)

1 reference

7 August 2017

Adrenergic Beta-Blocking Agents (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

15 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A13460

16 March 2022

author name string

R. P. Ahlquist

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A13460

16 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=13460

16 March 2022

publication date

1 January 1976

1 reference

full work available at URL

7 August 2017

http://link.springer.com/content/pdf/10.1007/978-3-0348-7094-8_2.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

16 March 2022

published in

1 reference

7 August 2017

volume

20

1 reference

7 August 2017

page(s)

27-42

1 reference

Propranolol in the therapy of angina pectoris

7 August 2017

cites work

1

18

366

PMS Gillam

1966

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

16 March 2022

2

2

725

BNC Pritchard

1964

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

PROPRANOLOL (INDERAL) IN DISTURBANCES OF CARDIAC RHYTHM

16 March 2022

3

1

891

DJ Rowlands

1965

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

A study of the adrenotropic receptors

16 March 2022

4

153

586

RP Ahlquist

1948

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Adrenergic receptors: a personal and practical view

16 March 2022

5

17

119

RP Ahlquist

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide)

16 March 2022

9

2

311

JW Black

1962

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

A NEW ADRENERGIC BETARECEPTOR ANTAGONIST

16 March 2022

10

1

1080

JW Black

1964

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Differentiation of receptors responsive to isoproterenol

16 March 2022

12

6

2241

AM Lands

1967

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

16 March 2022

21

287

1209

FR Buhler

1972

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon

16 March 2022

22

56

719

JJL Lertora

1975

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer

16 March 2022

26

7

226

EM Vaughn-Williams

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Selective blockade of beta-adrenoceptors by 1-(p-allylphenoxy)-3-isopropylamino-2 propanol hydrochloride (h 64-52) in the anaesthetized dog

16 March 2022

27

47

398

B Levy

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

The development of beta adrenergic blocking drugs: a retrospective and prospective evaluation

16 March 2022

28

139

649

NC Moran

1967

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

An analysis of selective beta receptor blockade

16 March 2022

29

5

227

B Levy

1968

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Prediction of the non-specific cardiodepressant effects of beta-adrenoceptor blocking agents in vitro and in vivo by means of the Hansch analysis

16 March 2022

32

29

223

D Hellenbrecht

1974

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise

16 March 2022

33

33

473

BNC Pritchard

1971

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Beta-adrenergic receptor blocking drugs in angina pectoris

16 March 2022

series ordinal

34

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Beta-adrenergic receptor blocking drugs in hypertension.

16 March 2022

35

7

85

FO Simpson

1974

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Beta-adrenergic receptor blocking drugs in cardiac arrhythmias

16 March 2022

37

7

461

BN Singh

1974

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

PROPRANOLOL (INDERAL) IN PERSISTENT VENTRICULAR FIBRILLATION

16 March 2022

38

1

895

G Sloman

1965

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Effects of beta adrenergic blockade with sotalol in chronic anxiety.

16 March 2022

42

14

418

PJ Tyrer

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Beta-adrenergic-receptor blockade with practolol in treatment of anxiety.

16 March 2022

44

1

814

JA Bonn

1972

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Propranolol and behavior of alcohol addicts after acute alcohol ingestion

16 March 2022

45

15

571

JH Mendelson

1974

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Beta-Adrenergic Mechanisms in Action Tremor

16 March 2022

46

293

950

RR Young

1975

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function

16 March 2022

series ordinal

48

0 references

Letter: Delayed fibrinous peritonitis after practolol treatment

50

4

40

D Allan

1975

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Drug therapy: Propranolol

16 March 2022

53

293

280

DG Shand

1975

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Haemodynamic effects of propranolol (Inderal) in acute myocardial infarction.

16 March 2022

55

1

141

G Bay

1967

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Beta-adrenergic blockade and cardiac arrhythmias

16 March 2022

56

4

508

G Sloman

1967

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle

16 March 2022

59

38

749

BN Singh

1970

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients

16 March 2022

60

193

189

J Castenfors

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Comparison of relative inotropic and chronotropic effects of propranolol, practolol, and sotalol.

16 March 2022

63

64

619

RE Goldstein

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Haemodynamics and myocardial function after sotalol

16 March 2022

64

34

787

I Hutton

1972

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Oxprenolol: Long-term effects in arterial hypertension

16 March 2022

65

14

995

EG Gysling

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Practolol in patients with angina pectoris.

16 March 2022

66

14

175

EL Alderman

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Effects of practolol on pressor responses to noxious stimuli in hypertensive patients

16 March 2022

67

14

165

Y Traub

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

16 March 2022

68

17

261

AH Gradman

1975

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man

16 March 2022

69

36

368

RC Hill

1969

0 references

Effect of pindolol, a beta receptor antagonist, in hyperthyroidism

74

14

158

JL Schelling

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man

16 March 2022

75

17

127

R Gugler

1975

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols

16 March 2022

77

16

1245

J Augustein

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents

16 March 2022

78

25

170

KR Adam

1974

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Treatment of acute arrhythmias with orally administered tolamolol

16 March 2022

79

63

917

WS Aronow

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Electrophysiologic effects of tolamolol on atrioventricular conduction in man

16 March 2022

80

90

755

JN Ruskin

1975

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension

16 March 2022

83

194

549

L Hansson

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

1-Isopropylamino-3-(4-indanoxy)-2-propanol HC1: a potent beta-adrenoreceptor antagonist

16 March 2022

86

39

139

B Levy

1970

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

16 March 2022

87

4

203

W Haefly

1967

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines

16 March 2022

88

16

1113

R.F. Meyer

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

N-substituted 2-amino-1-(2-thienyl)ethanols as beta-adrenergic blocking agents

16 March 2022

89

16

882

C Corral

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

-Adrenergic blocking agents of the chromone and xanthone groups

16 March 2022

90

15

198

P Dare

1972

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7094-8_2

16 March 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=13460

8 October 2022

1 reference